Glucosamine protects against neuronal but not vascular damage in experimental diabetic retinopathy
Glucosamine, an intermetabolite of the hexosamine biosynthesis pathway (HBP), is a widely used nutritional supplement in osteoarthritis patients, a subset of whom also suffer from diabetes. HBP is activated in diabetic retinopathy (DR). The aim of this study is to investigate the yet unclear effects...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
8 September 2021
|
| In: |
Molecular metabolism
Year: 2021, Volume: 54, Pages: 1-13 |
| ISSN: | 2212-8778 |
| DOI: | 10.1016/j.molmet.2021.101333 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.molmet.2021.101333 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2212877821001800 |
| Author Notes: | Rachana Eshwaran, Matthias Kolibabka, Gernot Poschet, Gregor Jainta, Di Zhao, Loic Teuma, Katharina Murillo, Hans-Peter Hammes, Martina Schmidt, Thomas Wieland, Yuxi Feng |
| Summary: | Glucosamine, an intermetabolite of the hexosamine biosynthesis pathway (HBP), is a widely used nutritional supplement in osteoarthritis patients, a subset of whom also suffer from diabetes. HBP is activated in diabetic retinopathy (DR). The aim of this study is to investigate the yet unclear effects of glucosamine on DR. |
|---|---|
| Item Description: | Gesehen am 22.11.2021 |
| Physical Description: | Online Resource |
| ISSN: | 2212-8778 |
| DOI: | 10.1016/j.molmet.2021.101333 |